H.R. 9011 · 117th Congress · House

Updated Drug Labeling for Patient Safety Act

Active· Referred to the Subcommittee on Health.
Introduced
Sep 28, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Updated Drug Labeling for Patient Safety Act

This bill allows generic drug manufacturers to revise labels with updated safety information that differs from the referenced brand-name drug.

Action Timeline

4
  1. SEP 29, 2022•Committee

    Referred to the Subcommittee on Health.

  2. SEP 28, 2022•IntroReferral

    Introduced in House

  3. SEP 28, 2022•IntroReferral

    Introduced in House

  4. SEP 28, 2022•IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Sep 29, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Sep 28, 2022

Active